Clinical Trial Update: INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for INcobotulinumtoxina in children with spastic cerebral palsy (INCIPIT) is ongoing, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spastic Cerebral Palsy

Drugs mentioned

• IncobotulinumtoxinA (incobotulinumtoxinA)

Snippet

Sponsor: Universita di Verona | Conditions: Spastic Cerebral Palsy | Phase 2 | Status: UNKNOWN